THE EFFECT OF NUCLEOSIDES AND DEOXYCOFORMYCIN ON ADENOSINE AND DEOXYADENOSINE INHIBITION OF HUMAN LYMPHOCYTE ACTIVATIONUBERTI J; LIGHTBODY JJ; JOHNSON RM et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 1; PP. 189-193; BIBL. 32 REF.Article

DETERMINATION OF ADENOSINE DEAMINASE ACTIVITY USING HIGH-PRESSURE LIQUID CHROMATOGRAPHY.UBERTI J; LIGHTBODY JJ; JOHNSON RM et al.1977; ANAL. BIOCHIM.; U.S.A.; DA. 1977; VOL. 80; NO 1; PP. 1-8; BIBL. 11 REF.Article

DECREASED LYMPHOCYTE ADENOSINE DEAMINASE ACTIVITY IN TUMOR PATIENTS.UBERTI J; JOHNSON RM; TALLEY R et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 6; PP. 2046-2047; BIBL. 10 REF.Article

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation : CD34⁺ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cellsCHOI, D; PERRIN, M; HOFFMANN, S et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2709-2716, issn 1078-0432Article

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCTMICALLEF, I. N; JACOBSEN, E. D; SHAUGHNESSY, P et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 303-304, issn 0268-3369, 2 p.Article

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access programSHAUGHNESSY, P; UBERTI, J; BALL, E. D et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 777-781, issn 0268-3369, 5 p.Article

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USADOUGLAS, K. W; PARKER, A. N; SCHEID, C et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 1, pp 18-23, issn 0268-3369, 6 p.Article

Transplantation in patients with multiple myeloma : A multicenter comparative analysis of peripheral blood stem cell and allogeneic transplantVARTERASIAN, M; JANAKIRAMAN, N; ADAMS, P. T et al.American journal of clinical oncology. 1997, Vol 20, Num 5, pp 462-466, issn 0277-3732Article

Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-α in patients with cancer : attempt to induce autologous graft-versus-host reaction to elicit an antitumor responseREDMAN, B. G; TA-HSU CHOU; ZALUPSKI, M et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 115-118, issn 1067-5582Conference Paper

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myelomaREYNOLDS, C; RATANATHARATHORN, V; FERRARA, J et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 8, pp 801-807, issn 0268-3369Article

Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC)RATANATHARATHORN, V; KARANES, C; SENSENBRENNER, L.L et al.Bone marrow transplantation (Basingstoke). 1992, Vol 9, Num 1, pp 49-55, issn 0268-3369Article

Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells : implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantationUBERTI, J; MARTILOTTI, F; TA-HSU CHOU et al.Blood. 1992, Vol 79, Num 1, pp 261-268, issn 0006-4971Article

Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of pH negative CMLMOHAMED, A. N; EBRAHIM, S. A. D; SARKAR, F. H et al.Cancer genetics and cytogenetics. 1995, Vol 80, Num 1, pp 60-62, issn 0165-4608Article

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphomaVORAVIT RATANATHARATHORN; UBERTI, J; KARANES, C et al.Blood. 1994, Vol 84, Num 4, pp 1050-1055, issn 0006-4971Article

Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromesVORAVIT RATANATHARATHORN; CHATCHADA KARANES; SENSENBRENNER, L. L et al.Blood. 1993, Vol 81, Num 8, pp 2194-2199, issn 0006-4971Article

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer : the University of Michigan experience and literature reviewAYASH, L. J; CLARKE, M; SILVER, S. M et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 9, pp 939-947, issn 0268-3369Article

Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patientsJACOBSON, P; NG, J; RATANATHARATHORN, V et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 8, pp 753-758, issn 0268-3369Article

Tacrolimus : a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantationJACOBSON, P; UBERTI, J; DAVIS, W et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 3, pp 217-225, issn 0268-3369Article

Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantationRATANATHARATHORN, V; UBERTI, J; KARANES, C et al.Bone marrow transplantation (Basingstoke). 1994, Vol 13, Num 5, pp 625-630, issn 0268-3369Article

Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomasCHERUKU, R; UBERTI, J; MARTILOTTI, F et al.Transplantation. 1993, Vol 56, Num 4, pp 1037-1040, issn 0041-1337Article

Bronchiolitis obliterans following haematopoietic stem cell transplantationSOUBANI, A. O; UBERTI, J. P.The European respiratory journal. 2007, Vol 29, Num 5, pp 1007-1019, issn 0903-1936, 13 p.Article

THE EFFECT OF ADENOSINE ON MITOGENESIS OF ADA-DEFICIENT LYMPHOCYTES.UBERTI J; LIGHTBODY JJ; WOLF JW et al.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1978; VOL. 10; NO 4; PP. 446-458; BIBL. 25 REF.Article

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHDMELLON-REPPEN, S; RATANATHARATHORN, V; CRONIN, S et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 12, pp 1758-1759, issn 0268-3369, 2 p.Article

Do negative or positive emotions differentially impact mortality after adult stem cell transplant?HOODIN, F; UBERTI, J. P; LYNCH, T. J et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 4, pp 255-264, issn 0268-3369, 10 p.Article

Chronic graft-versus-host disease: clinical manifestation and therapyRATANATHARATHORN, V; AYASH, L; LAZARUS, H. M et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 2, pp 121-129, issn 0268-3369Article